Select a month January 2004 December 2003 November 2003" October 2003 September 2003 July 2003 June 2003 May 2003 April 2003 March 2003 February 2003 January 2003 December 2002 November 2002 October 2002 September 2002 August 2002 July 2002 June 2002 May 2002 April 2002 March 2002 February 2002 January 2002 December 2001 November 2001 October 2001

Studies in Humans: Other (Definition) Jump to: 2003: January  |  February  |  March  |  April  |   May  |   June  |   July  |   2002: January  |  February  |  March  |  April  |  May  |  June  |  July  |  August  |  September  |  October  |  November  |  December   2001: October  |  November  |  December July 2003 Boys A, Marsden J. (2003) Perceived functions predict intensity of use and problems in young polysubstance users. Addiction 8:951-963. June 2003 No updates located for June 3003 May 2003 Forrest AR (2003) Dataset on deaths related to taking ecstasy looks incomplete. Bmj 326: 823. April 2003 No updates available for April 2003. March 2003 De Letter EA, Espeel MF, Craeymeersch ME, Lambert WE, Clauwaert KM, Dams R, Mortier KA, Piette MH (2003) Immunohistochemical demonstration of the amphetamine derivatives 3,4- methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland. Int J Legal Med 117: 2-9. Peters FT, Maurer HH, Hellstern P (2003) Prevalence of illicit drug use in plasmapheresis donors. Vox Sang 84: 91-5. Simonsen KW, Kaa E, Nielsen E, Rollmann D (2003) Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000. Forensic Sci Int 131: 162-70 February 2003 Gilhooly TC, Daly AK (2002) CYP2D6 deficiency, a factor in ecstasy related deaths? Br J Clin Pharmacol 54: 69-70 January 2003 Schifano F, Oyefeso A, Webb L, Pollard M, Corkery J, Ghodse AH (2003) Review of deaths related to taking ecstasy, England and Wales, 1997- 2000. Bmj 326: 80-81. December 2002 Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA (2002) The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97: 1531-1536. November 2002 No updates available for November 2002. October 2002 No updates available for October 2002. September 2002 Baggott M (2002). Preventing problems in ecstasy users; Reduce use to reduce harm. J Psychoactive Drugs, 34: 145-162. Doblin R (2002). A clinical plan for MDMA (ecstasy) in the treatment of post-traumatic stress disorder (PTSD): Partnering with the FDA. J Psychoactive Drugs, 34; 185-194. Hayner, GN (2002). MDMA misrepresentation: An unresolved problem for ecstasy users. J Psychoactive Drugs, 34; 195-198. Landry M (2002). MDMA: A review of epidemiologic data. J Psychoactive Drugs, 34; 163-169. McElrath K, McEvoy K (2002). Negative experiences on ecstasy: The role of drug. Set and setting. J Psychoactive Drugs, 34: 199-208. Nencini P (2002). The shaman and the rave party: social pharmacology of ecstasy. Subst Use Misuse 37: 923-39. Raikos N, Tsoukali H, Psaroulis D, Vassiliadis N, Tsoungas M, Njau S (2002). Amphetamine derivative related deaths in northern Greece. Forensic Sci Int 128: 31-34. Rosenbaum M (2002). MDMA: America's new "reefer madness?" J Psychoactive Drugs 34: 137-142. August 2002 No updates available for August 2002. July 2002 Cherney DZ, Davids MR, Halperin ML (2002). Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis. Qjm 95: 475-483. Gill JR, Hayes JA, deSouza IS, Marker E, Stajic M (2002). Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forensic Sci 47: 121-126. Hartung TK, Schofield E, Short AI, Parr MJ, Henry JA (2002). Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion. Qjm 95: 431-437. June 2002 No updates available for June 2002. May 2002 No updates available for May 2002. April 2002 Zagnoni PG, Albano C (2002). Psychostimulants and epilepsy. Epilepsia 43: 28-31 March 2002 Bateman DN, Good AM, Laing WJ, Kelly CA (2002). TOXBASE: poisons information on the internet. Emerg Med J 19: 31-4. February 2002 No updates available for February 2002. January 2002 Ho E, Karimi-Tabesh L, Koren G (2001). Characteristics of pregnant women who use Ecstasy (3, 4- methylenedioxymethamphetamine). Neurotoxicol Teratol 23: 561-7. McElrath K, McEvoy K (2001). Fact, fiction, and function: mythmaking and the social construction of ecstasy use. Subst Use Misuse 36: 1-22. Soar K, Turner, JJD, Parrott, AC (2001). Psychiatric disorders in Ecstasy (MDMA) users; a literature review focusing on personal predisposition and drug history. Hum Psychopharamcol Clin Exp, 16: 641-64 December 2001 Logan BK, Couper FJ (2001). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46: 1426-33. November 2001 Boys, A, Marsden, J and Strang, J (2001). Understanding reasons for drug use amongst people; A functional perspective. Health Education Research, 16: 457-469. McCann, UD, Ricaurte, GA, Molliver, ME (2001). "Ecstasy" and serotonin neurotoxicity. Archives of General Psychiatry, 58: 907-908. Mattison, AM, Ross, MW, Wolfson, T and Franklin, D (2001). Circuit party attendance, club drug use, and unsafe sex in gay men. Journal of Substance Abuse, 13: 119-126. October 2001 No updates available for October 2001.